Curis reported $0 in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Amgen AMGN:US $ 36010M 2788M
AstraZeneca AZN:LN 28805M 83M
Bayer BAYN:GR € 36648M 167M
Bristol Myers Squibb BMY:US $ 37450M 2155M
Chimerix CMRX:US $ 0 0
Curis CRIS:US $ 0M 0M
Eli Lilly And LLY:US $ 15152.9M 193.5M
Epizyme EPZM:US $ 232.49M 379K
Exelixis EXEL:US $ 0M 0M
Gilead Sciences GILD:US $ 25183M 4M
GlaxoSmithKline GSK:LN 29226M 8654M
Merk MRK:US $ 30586M 104M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 24373M 150M
Pfizer PFE:US $ 35656M 539M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Takeda 4502:JP Y 4141418M 90521M
Tg Therapeutics TGTX:US $ 67.25M 0.46M
Verastem VSTM:US $ 24.41M 24.16M
Xoma XOMA:US $ 0 0
YTE INCY:US $ 31.38M 0.25M
Ziopharm Oncology ZIOP:US $ 10.32M 5.93M